Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Assistance Publique Hopitaux De Marseille
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients (male or female) ≥ 18 years of age.
Patients with histologically documented, locally advanced or recurrent (stage IIIB) or metastatic (Stage IV) non-small cell lung Cancer or malignant pleural mesothelioma, for which no standard exits.
Presence of at least one measurable lesion according to RECIST v.1.1 for NSCLC and modified RECIST 1.1 for MPM
ECOG performance status ≤2
You may not be if
ECOG performance status \>2
Patients with significant or uncontrolled cardiovascular disease (eg, congestive heart failure, angor, arrhythmia) within 6 months of starting study treatment
Any neurological or psychiatric condition interfering with the understanding of study
Infectious condition uncontrolled
Any other medical condition that would jeopardize the subject participation
Clareo Health | Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM
